Price Vision Group Blog

Price Vision Group Becomes First in Indiana to Treat Degenerative Corneal Disease, Neurotrophic Keratitis, with New FDA-Approved Drug

  Indianapolis, IN – Dr. Matthew Feng of Price Vision Group will be the first ophthalmologist in Indiana to use the new FDA-approved drug, Oxervate™ (cenegermin). The patient, Tina Hunter, has vision loss due to neurotrophic keratitis (NK). NK is a rare, degenerative corneal disease for which previous treatments include artificial tears or autologous serum tears, which are custom made from a patient’s…

Read more

How Does Cornea Thickness Affect My Candidacy For LASIK?

When a patient comes to our office for a LASIK screening, one of the first things we check for is cornea thickness. So why is cornea thickness important for LASIK? During LASIK, an excimer laser is used to remove tissue (ablation) and reshape the cornea so images can focus accurately onto the retina. Since corneal tissue is permanently removed during the LASIK procedure,…

Read more

Price Vision Group to Become First in US to Perform LIKE Procedure

Pioneering cornea surgeon Francis W. Price, Jr., MD of Price Vision Group in Indianapolis, IN is scheduled to become the first in the U.S. to perform the revolutionary LIKE procedure. LIKE (LASIK and Intrastromal Keratoplasty) is the next generation in refractive surgery to correct extreme farsightedness in people who cannot be helped by current LASIK or refractive techniques. Clear, focused vision depends on…

Read more

Price Vision Group Becomes First in Indiana to Implant Visian Toric ICL

Indianapolis, IN, November 8, 2018 – Price Vision Group is the first practice in Indiana to implant the new FDA-approved Visian Toric ICL from STAAR Surgical. This new implantable collamer lens (ICL) provides a new solution for patients with moderate to high levels of myopia and astigmatism ‒ in one simple procedure. Previously, ICL patients with astigmatism would need a separate LASIK…

Read more

FDA Approves Visian Toric ICL for astigmatism. What it means.

On September 13, 2018, STAAR Surgical announced the approval by the FDA of the Visian Toric ICL (TICL) for the correction of myopia with astigmatism. Before the announcement, the Visian ICL (implantable collamer lens) product line in the United States only consisted of lenses that offer correction for patients with myopia (nearsightedness). Visian ICL patients with astigmatism would require an…

Read more

Dr. Francis W. Price, Jr. to Receive Thomas C. Hasbrook Award

INDIANAPOLIS—Bosma Enterprises, an Indianapolis-based nonprofit organization dedicated to creating opportunities for Hoosiers who are blind or visually impaired, is set to honor two prominent supporters at its annual Hasbrook Awards Luncheon. The event will be held Nov. 2 at The Crane Bay, 551 W. Merrill St., Indianapolis, to raise funds for employment and training programs. During the luncheon, Bosma will…

Read more

Price Vision Group to Participate in National Sight Week

Price Vision Group to Participate in National Sight Week Local Eye Surgeons Will Provide Free Cataract Surgery   Indianapolis, IN – Price Vision Group is pleased to announce its participation in the 2nd annual National Sight Week (October 15-21), sponsored by the American Society of Cataract & Refractive Surgery (ASCRS) Foundation. During National Sight Week, Dr. Francis Price, Jr, Dr.…

Read more

Advancements in Cell Regeneration Not Yet as Reliable as DMEK in Fuchs’ dystrophy

Advancements in Cell Regeneration Not Yet as Reliable as DMEK in Fuchs’ dystrophy  By Francis W. Price, Jr., MD & Matthew T. Feng, MD We are always looking for better ways to correct the visual difficulties of patients with Fuchs’ dystrophy.  In fact, that is why we helped pioneer the evolution of corneal transplants from full thickness grafts (penetrating keratoplasty)…

Read more

Dr. Francis Price, Jr. Performs First XEN® Gel Stent Procedure in Indiana on Glaucoma Patient

Indianapolis, IN – August 4, 2017 – Dr. Francis Price Jr., of the Price Vision Group and one of the top cornea specialists in the world, added another “first” to his distinguished credentials in the field of ophthalmology. Having been the first in the state of Indiana to perform several refractive surgeries such as LASIK, all-laser LASIK and CONTOURA™ Vision…

Read more

Dr. Matthew T. Feng: One to Watch!

Matthew T. Feng, MD has been profiled as “One to Watch” by MillennialEYE Magazine! Dr. Feng is a cataract, LASIK, and corneal transplant surgeon at Price Vision Group. The distinction recognizes a “rising star” in ophthalmology. Congratulations, Dr. Feng!  You can read the article right now by Clicking here.

Back to Top

Contact Us

Required fields

DO NOT USE THIS FORM IF YOU HAVE AN URGENT NEED TO BE SEEN. CALL OUR OFFICE.

By checking the box on the contact form, you agree to the Terms of Use listed here: Communications through our website or via email are not encrypted and are not necessarily secure. Use of the internet or email is for your convenience only, and by using them, you assume the risk of unauthorized use. By checking this box you hereby agree to hold Price Vision Group, its doctors and affiliates, harmless from any hacking or any other unauthorized use of your personal information by outside parties.

Indianapolis, IN
(800) 317-3937

Price Vision Group 9002 North Meridian Street #100
Indianapolis, IN 46260
Monday–Friday: 8 a.m.–5 p.m.
(317) 844-5530


Price Vision Group is a global leader in corneal transplant, cataract surgery, keratoconus treatment, PRK and LASIK. At our center in Indianapolis, we see patients from Indiana cities including Fishers, Carmel, Noblesville, Avon, and Greenwood, as well as people who travel from across the U.S. and even abroad for treatment by our renowned physicians.

Website Design & Marketing by Etna Interactive